• Turnover in 2011 – 52,2 millions Euro;
  • Post-tax profit in 2011 – 9,7 millions Euro;
  • Number of company employees – 885 (on March 1, 2012);
  • Major export markets – Russia, Ukraine, Belorussia, Kazakhstan;
  • Exports volume in 2010 – 33 millions Euro;
  • Farthest export market for JSC Olainfarm – Australia;
  • In total, for all markets, JSC Olainfarm produces around 60 types of medicine and around 30 pharmaceutical agents;
  • Representatives of the JSC Olainfarm are present in 10 countries;
  • Only 5-10% of the total JSC Olainfarm products are realized on the Latvian market.
About JSC Olainfarm

The two main areas of JSC Olainfarm operation are:

  • Manufacturing of oral dosage medicament forms;
  • Manufacturing of chemical ingredients and active pharmaceutical ingredients.

The range of products manufactured by JSC Olainfarm include:

  • 7 original products: Bikarfen, Etacizin, Noofen, Fenkarol, Furagin, Neiromidin, Adaptol;
  • 26 non-proprietary (generic) medicaments;
  • More than 25 active pharmaceutical ingredients.


Joint stock company Olainfarm is one of the largest companies in the Baltic States with almost 40 years of experience in production of medicaments and chemical pharmaceutical products. The key principle of the Company is manufacturing of reliable and effective high quality products to the whole world. Products of JSC Olainfarm are exported to more than 30 countries, including the Baltic States, Russia, other CIS countries, Scandinavian, Western European and Asian countries, as well as North America and Australia.

The Company was founded in 1972 as state enterprise “Olaines ķīmiski – farmaceitiskā rūpnīca” (Olaine Chemical-Pharmaceutical Plant). The main goal of founding the Company was to ensure pharmaceutical substances and semiproducts to several finished drug form manufacturing plants in the Soviet Union. As a result of privatization in 1997, the Company was reorganized into a joint stock company and its shares were listed on stock exchange. Starting from 1 December 2006, shares of JSC Olainfarm are listed in the Main List of stock exchange NASDAQ OMX Riga.

Currently, nearly 800 highly qualified experts are employed by JSC Olainfarm in Latvia. The Company is equipped with advanced technologies and is certified according to the requirements of Good Management Practice (GMP) of the European Union, Environmental Management Standard ISO 14001:2004.

Proof of the high quality of the Company’s products is cooperation with global and regionally acknowledged companies as “Novartis”, “Ranbaxy”, “Glenmark Generics”, “Cobalt”, “Almirall Ranke”, “UQUIFA”, “MIAT”, “Aspen AU”, “Loba”, “PHF” and many others.